How Revenue Assumptions Are Rewriting The Story For Castle Biosciences (CSTL) [Yahoo! Finance]
Castle Biosciences, Inc. - Common stock (CSTL)
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Castle Biosciences is back in focus as one firm's price target shift from US$35 to US$52 draws attention to how small changes in revenue assumptions can reshape upside scenarios. That move is part of a broader pattern, where analysts are tying targets more closely to 2026 revenue frameworks and the company's preliminary 2025 revenue disclosure. As you read on, you will see how to track these evolving inputs so you can follow the narrative as it develops. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Castle Biosciences. What Wall Street Has Been Saying ?? Bullish Takeaways Lake Street lifted its Castle Biosciences price target to US$52 from US$35 after the company released preliminary 2025 revenue, signaling higher conviction in the revenue outlook used in its 2026 model. Lake Street is now anchoring valuation to 2026 revenue estimates, which points to a longer term framework rather than a near term tradi
Show less
Read more
Impact Snapshot
Event Time:
CSTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSTL alerts
High impacting Castle Biosciences, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CSTL
News
- The Melanoma Research Foundation Launches its Inaugural Washington DC 5K Fundraiser with a Goal of $115,000 in Support of Melanoma Research, Education and AdvocacyPR Web
- Castle Biosciences inks expansion at Nova Place [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026 [TheStreet.com]TheStreet.com
- Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026PR Newswire
- Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive YearPR Newswire
CSTL
Earnings
- 2/26/26 - Beat
CSTL
Sec Filings
- 4/8/26 - Form 4
- 4/8/26 - Form ARS
- 4/8/26 - Form DEF
- CSTL's page on the SEC website